Cargando…
Quantitative Proteomics Reveal That Metabolic Improvement Contributes to the Cardioprotective Effect of T(89) on Isoproterenol-Induced Cardiac Injury
BACKGROUND: T(89), a traditional Chinese medicine, has passed phase II, and is undergoing phase III clinical trials for treatment of ischemic cardiovascular disease by the US FDA. However, the role of T(89) on isoproterenol (ISO)-induced cardiac injury is unknown. The present study aimed to explore...
Autores principales: | Wei, Xiao-Hong, Guo, Xiao, Pan, Chun-Shui, Li, Huan, Cui, Yuan-Chen, Yan, Li, Fan, Jing-Yu, Deng, Jing-Na, Hu, Bai-He, Chang, Xin, He, Shu-Ya, Yan, Lu-Lu, Sun, Kai, Wang, Chuan-She, Han, Jing-Yan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8273540/ https://www.ncbi.nlm.nih.gov/pubmed/34262469 http://dx.doi.org/10.3389/fphys.2021.653349 |
Ejemplares similares
-
Post-treatment With Qing-Ying-Tang, a Compound Chinese Medicine Relives Lipopolysaccharide-Induced Cerebral Microcirculation Disturbance in Mice
por: Wang, Hao-Min, et al.
Publicado: (2019) -
Cardioprotective Effects of Aconite in Isoproterenol-Induced Myocardial Infarction in Rats
por: Xing, Ziwei, et al.
Publicado: (2022) -
Cardioprotective Effect of Paeonol and Danshensu Combination on Isoproterenol-Induced Myocardial Injury in Rats
por: Li, Hua, et al.
Publicado: (2012) -
The Contribution of Different Components in QiShenYiQi Pills® to Its Potential to Modulate Energy Metabolism in Protection of Ischemic Myocardial Injury
por: Cui, Yuan-Chen, et al.
Publicado: (2018) -
Cardiotonic Pills Plus Recombinant Human Prourokinase Ameliorates Atherosclerotic Lesions in LDLR(–/–) Mice
por: Deng, Jing-Na, et al.
Publicado: (2019)